Logo
x

Search

Subscribe Now

Eli Lilly

Eli Lilly Acquires OLX75016 from OliX Pharmaceuticals for Metabolic-Associated Steatohepatitis

Eli Lilly Acquires OLX75016 from OliX Pharmaceuticals for Metabolic-Associated Steatohepatitis

  • February 11, 2025
Eli Lilly Reveals VIVID-2 Study Data of Omvoh to Treat Crohn's Disease

Eli Lilly Reveals VIVID-2 Study Data of Omvoh to Treat Crohn's Disease

  • February 10, 2025
Eli Lilly Receives the US FDA’s Approval for Omvoh (Mirikizumab-mrkz) to Treat Crohn's Disease (CD)

Eli Lilly Receives the US FDA’s Approval for Omvoh (Mirikizumab-mrkz) to Treat Crohn's Disease (CD)

  • January 16, 2025
Eli Lilly Inks ~2.5B Deal to Acquire Scorpion Therapeutics

Eli Lilly Inks ~2.5B Deal to Acquire Scorpion Therapeutics

  • January 14, 2025
Eli Lilly Reports the US FDA’s Approval of Zepbound (Tirzepatide) to Treat Moderate-to-Severe Obstructive Sleep Apnea in Obese Adults

Eli Lilly Reports the US FDA’s Approval of Zepbound (Tirzepatide) to Treat Moderate-to-Severe Obstructive Sleep Apnea in Obese Adu...

  • December 23, 2024
Eli Lilly Reports Kinsula (Donanemab-Azbt) Approval in China to Treat Early Symptomatic Alzheimer's Disease

Eli Lilly Reports Kinsula (Donanemab-Azbt) Approval in China to Treat Early Symptomatic Alzheimer's Disease

  • December 19, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.